Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001178913-26-001750
Filing Date
2026-03-26
Accepted
2026-03-26 08:41:16
Documents
2
Period of Report
2026-03-18

Document Format Files

Seq Description Document Type Size
1 FORM 3 zk2634962.html 3  
1 FORM 3 zk2634962.xml 3 4892
2 EXHIBIT 24 exhibit_24.htm EX-24 8575
  Complete submission text file 0001178913-26-001750.txt   15055
Mailing Address JERUSALEM BIOPARK, 2ND FLOOR HADASSAH EIN KEREM CAMPUS JERUSALEM L3 00000
Business Address JERUSALEM BIOPARK, 2ND FLOOR HADASSAH EIN KEREM CAMPUS JERUSALEM L3 00000 972-8-9302529
Scinai Immunotherapeutics Ltd. (Issuer) CIK: 0001611747 (see all company filings)

EIN.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address 27 HAILANOT HERZLIYA L3 4631214
Business Address
Mark Elad (Reporting) CIK: 0001960205 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-37353 | Film No.: 26794490